GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpine Immune Sciences Inc (FRA:34LA) » Definitions » Cyclically Adjusted Book per Share

Alpine Immune Sciences (FRA:34LA) Cyclically Adjusted Book per Share : €7.06 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alpine Immune Sciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Alpine Immune Sciences's adjusted book value per share for the three months ended in Mar. 2024 was €4.669. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.06 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-03), Alpine Immune Sciences's current stock price is €59.00. Alpine Immune Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €7.06. Alpine Immune Sciences's Cyclically Adjusted PB Ratio of today is 8.36.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Alpine Immune Sciences was 8.12. The lowest was 1.46. And the median was 2.51.


Alpine Immune Sciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Alpine Immune Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpine Immune Sciences Cyclically Adjusted Book per Share Chart

Alpine Immune Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 7.24

Alpine Immune Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.80 5.85 7.24 7.06

Competitive Comparison of Alpine Immune Sciences's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Alpine Immune Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpine Immune Sciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpine Immune Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alpine Immune Sciences's Cyclically Adjusted PB Ratio falls into.



Alpine Immune Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alpine Immune Sciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.669/131.7762*131.7762
=4.669

Current CPI (Mar. 2024) = 131.7762.

Alpine Immune Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 -3.810 99.070 -5.068
201503 -5.488 99.621 -7.259
201506 21.940 100.684 28.715
201509 20.615 100.392 27.060
201512 19.828 99.792 26.183
201603 17.739 100.470 23.266
201606 15.792 101.688 20.465
201609 14.275 101.861 18.467
201612 13.505 101.863 17.471
201703 11.758 102.862 15.063
201706 10.475 103.349 13.356
201709 5.015 104.136 6.346
201712 4.821 104.011 6.108
201803 4.327 105.290 5.416
201806 4.113 106.317 5.098
201809 3.402 106.507 4.209
201812 2.829 105.998 3.517
201903 2.698 107.251 3.315
201906 2.163 108.070 2.637
201909 1.701 108.329 2.069
201912 1.427 108.420 1.734
202003 1.210 108.902 1.464
202006 0.775 108.767 0.939
202009 2.406 109.815 2.887
202012 2.147 109.897 2.574
202103 1.875 111.754 2.211
202106 1.521 114.631 1.748
202109 3.573 115.734 4.068
202112 3.544 117.630 3.970
202203 3.460 121.301 3.759
202206 3.104 125.017 3.272
202209 4.177 125.227 4.395
202212 3.683 125.222 3.876
202303 3.316 127.348 3.431
202306 3.183 128.729 3.258
202309 3.074 129.860 3.119
202312 4.983 129.419 5.074
202403 4.669 131.776 4.669

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Alpine Immune Sciences  (FRA:34LA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Alpine Immune Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=59.00/7.06
=8.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Alpine Immune Sciences was 8.12. The lowest was 1.46. And the median was 2.51.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Alpine Immune Sciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Alpine Immune Sciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpine Immune Sciences (FRA:34LA) Business Description

Traded in Other Exchanges
Address
188 East Blaine Street, Suite 200, Seattle, WA, USA, 98102
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company dedicated to discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its pipeline candidates are; ALPN-303, or povetacicept, is a dual antagonist of the B cell activating factor, or BAFF, and a proliferation-inducing ligand, or APRIL, cytokines, which play key roles in the activation, development, and survival of B cells, and ALPN-101, or acazicolcept, is a dual Inducible T cell Costimulator, or ICOS, and CD28 antagonist intended for the treatment of autoimmune and inflammatory diseases.

Alpine Immune Sciences (FRA:34LA) Headlines

No Headlines